Searched for
BAYER LITIGATION ISSUES
Top cases on the United States Supreme Court's docketThe U.S. Supreme Court is reviewing significant cases. These cases cover voting rights, presidential authority, immigration policies, and g...
'India has intellectual power to be a leader in biomedical innovation,' says Bayer AGBayer's CEO Bill Anderson believes India can become a top pharmaceutical market. He highlights the need for supportive policy frameworks, i...
Bayer CEO: we will have to stop producing glyphosate if nothing changesBayer may halt U.S. production of glyphosate, a widely used weedkiller, due to ongoing litigation. CEO Bill Anderson stated that without re...
Farm startups bent on shaking up Cargill, ADM are stumblingStartups in the agriculture sector, like Indigo Ag Inc., Gro Intelligence, and Farmers Edge Inc., are facing challenges as they struggle to...
Biocon Biologics settles patent issue; paves way for launch of biosimilar product in CanadaBiocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalm...
Bayer's Monsanto, India's NSL settle long-running intellectual property disputeIn a statement to Reuters, the German company said it had resolved "outstanding issues and differences" over the dispute, giving no further...
Bayer gets over compulsory licence“India is a large market and we will get through the challenges that are there. It is never easy but we also see huge potential in the Indi...
Delhi High Court notice to government over MNCs' patent disclosureThe petition exposes the weak enforcement of an important statutory provision, Form 27, which discloses patent data of a company.
PM Narendra Modi’s push for GM crops faces tough opposition from Swadeshi Jagaran ManchThe GM crops issue will test the Swadeshi Jagaran Manch’s will as well as the resolve of Narendra Modi's government.
Veerappa Moily to seed a change, likely to approve GM food crops in IndiaThe new minister will need to take a decision on the GM issue soon, as the government is required to file an affidavit in the Supreme Court...
Indian patent law doesn't discriminate against US companies: IPAIndian Pharma Alliance (IPA) writes to Roy Waldron after he slammed country's IP policy as protectionist and discriminatory.
Only 3% of patents filed by MNC pharma firms under dispute: StudyPatent experts say few drugmakers are challenging frivolous drug patents and the Indian patent office is actually liberal in granting paten...
- Natco Pharma, Bristol-Myers Squibb face off in Court over sale of dasatinib clone
Hyderabad-based Natco says it has not reneged on its undertaking as its version of the drug is different and does not infringe upon the pat...
- Microsoft Word may get a facelift, post patent loss
The company has time till January 11 to make change or stop sales of the Microsoft Word software.
- Major win for Indian pharma cos as HC dismisses Bayer petition
The Delhi High Court (HC) on Tuesday dismissed German drug major Bayer Healthcare’s attempt to stop Drug Controller General of India (DCGI)...